Authors
Y Dauvilliers, I Arnulf, Z Szakács, C Scart-Grès, I Lecomte, C Caussé, J Schwartz
Publication date
2018/4/1
Journal
Sleep
Volume
41
Pages
A231
Publisher
Oxford University Press
Description
The HARMONY III study is assessing long-term (up to 5 years) safety and efficacy of pitolisant, the first potent and highly selective histamine H3-receptor antagonist/inverse agonist, in the treatment of patients with narcolepsy.
Scholar articles
Y Dauvilliers, I Arnulf, Z Szakács, C Scart-Grès… - Sleep, 2018